PATENT CLAIM ANALYSIS

Application Number: 15898128
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "04400A"]

Abstract:
Compounds, compositions and methods are provided for modulating the expression of transthyretin. The compositions comprise oligonucleotides, targeted to nucleic acid encoding transthyretin. Methods of using these compounds for modulation of transthyretin expression and for diagnosis and treatment of diseases and conditions associated with expression of transthyretin are provided.

Claim (Index 37):
The combination of  claim 32 , wherein the anti-inflammatory drug is a corticosteroid.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 88.0
- Lexical Diversity: 1.60606
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12273731', '12710232', '10704263', '11556565', '10418780']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8017304899050895
- 35 USC 102 Novelty (BERT): 0.5314516045367973
- Combined Prediction Score: 0.7747026013682603
- Mean Citation Score: 275.872358
- Max Citation Score: 343.36108
- Similarity Product: 183.1951141433954

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test